Skip to content

Effect of Zhong-Yu-Ke-Li on pregnancy outcome after laparoscopic IUI in patients with endometriosis

Effect of Zhong-Yu-Ke-Li on pregnancy outcome after laparoscopic IUI in patients with endometriosis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2024000277
Enrollment
Unknown
Registered
2024-08-20
Start date
2024-08-25
Completion date
Unknown
Last updated
2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

endometriosis

Interventions

control group:Zhong-Yu-Ke-Li placebo+ovulation induction with IUI
Chinese medicine group:Zhong-Yu-Ke-Li+ovulation induction with IUI

Sponsors

First Teaching Hospital of Tianjin University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 35 Years

Inclusion criteria

Inclusion criteria: 1. Women aged 20~35 with reproductive needs; 2. Meet the clinical diagnostic criteria for endometriosis, first laparoscopic surgical treatment, and histologically confirmed to be consistent with the diagnosis of endometriosis; 3. Failure to conceive 6-12 months after laparoscopic surgery; 4. Normal ovarian reserve function (AMH =1.1ng/ml) and regular menstrual cycles in the past (28±7 days); 5. EFI score = 5; 6. Hysterosalpingography or laparoscopic tubal fluids within 1 year showed that the fallopian tubes were patent bilaterally or on one side; 7. Normal semen of the male partner; 8. Volunteers to be subjected to the test and agrees to sign the informed consent.

Exclusion criteria

Exclusion criteria: 1.Adenomyosis, uterine fibroids (submucous fibroids or non-submucous fibroids but with fibroid size >3cm and/or endometrial compression), endometrial polyps, and other organic lesions of reproductive organs; 2. Patients with infertility caused by male factors; 3. Combination of endocrine disorders affecting pregnancy (e.g., polycystic ovary syndrome, thyroid disease, hyperprolactinemia, adrenal tumors, etc.); 4. Combined serious diseases of the heart, kidneys, liver and other vital organs, as well as cognitive disorders and psychiatric disorders; 5. Medications or complementary therapies related to endometriosis (including: acupuncture, Chinese herbs, proprietary Chinese medicines, and other complementary and alternative medicine therapies) within the last 8 weeks.

Design outcomes

Primary

MeasureTime frame
live birth rate;

Secondary

MeasureTime frame
Biochemical pregnancy rate;abortion rate;Ongoing pregnancy rate;Dysmenorrhea VAS score;Clinical pregnancy rate;Recurrence rate of endometriosis;Multimodal evaluation parameters;

Countries

China

Contacts

Public ContactWu Linling

First Teaching Hospital of Tianjin University of Traditional Chinese Medicine

1115387712@qq.com13642123194

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026